Bioretec Oy Stock BOERSE MUENCHEN

0TN

FI4000480454

Medical Equipment, Supplies & Distribution

Real-time BOERSE MUENCHEN Other stock markets 15:44:14 2026-07-27 EDT			5-day change	1st Jan Change
0.0180 ^EUR	0.00%		-17.43%	-68.62%

07-02	Bioretec's CFO Steps Down	MT
07-02	Bioretec Ltd Announces CFO Changes, Effective July 2, 2026	CI

Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oyâ€™s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Companyâ€™s products are used all over the world.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

08-12 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change
26-07-27	€0.0180	0.00%
26-07-24	€0.0180	0.00%
26-07-23	€0.0180	0.00%
26-07-22	€0.0180	-17.43%
26-07-21	€0.0218	0.00%

Real-time BOERSE MUENCHEN

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.0214EUR

Average target price

0.0260EUR

Spread / Average Target

+21.50%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	28.45M 32.36M 26.48M 24.32M 45.66M 3.1B 46.27M 315M 123M 1.53B 121M 119M 5.3B	P/E 2025	-0.07x	P/E 2026 *	-2.12x
Enterprise Value	24.05M 27.35M 22.38M 20.56M 38.6M 2.62B 39.11M 266M 104M 1.3B 103M 100M 4.48B	EV / Sales 2025	6.95x	EV / Sales 2026 *	3.87x
Free-Float	99.48%	Yield 2025 *	-	Yield 2026 *	-

07-02	Bioretec's CFO Steps Down	MT
07-02	Bioretec Ltd Announces CFO Changes, Effective July 2, 2026	CI
06-17	Bioretec Oy Appoints Conan Cavanagh as Head of Research & Development and Member of the Management Team as of 1 September 2026	CI
06-17	Bioretec to Terminate Three Production Roles in Finland	MT
06-06	Bioretec Ltd Announces U.S. Department of Health and Human Services Food and Drug Administration Issues a Final Order	CI
06-02	Bioretec Launches Change Negotiations Across Finnish Production Business	MT
05-13	Bioretec clarifies its 2026-2028 financial target regarding the sales margin	RE
05-13	Bioretec clarifies 2026-2028 financial target regarding sales margin	RE
05-08	Bioretec Ltd Announces Board Changes	CI
04-27	Bioretec Raises EUR13 Million from Rights Offering	MT
04-24	Bioretec says 1.29 bln new shares were subscribed for in rights issue	RE
04-23	Bioretec announces preliminary results from rights issue	RE
04-20	Bioretec Oy Announces Stepping Down of Sarah Van Hellenberg Hubar-Fisher as A Member of the Board of Directors	CI

07-07	The Board of Directors of Bioretec Ltd resolved on a new stock option plan	AQ
07-02	Inside information: Chief Financial Officer Tuukka Paavola will leave the company	AQ
06-17	Bioretec appoints Conan Cavanagh as Head of Research & Development and member of the Management Team	AQ
06-17	Bioretec concludes change negotiations	AQ
06-04	Bioretec Ltd - Manager's transactions - van Hellenberg Hubar-Fisher	AQ

1 week	-17.43%
Current month	-16.67%
1 month	-16.67%
3 months	-20.35%
6 months	-56.67%
Current year	-68.62%

Manager	Title	Age	Since
Sarah Frances van Hellenberg Hubar-Fisher CEO	Chief Executive Officer	48	2025-05-14
Tuukka Paavola DFI	Director of Finance/CFO	46	2026-01-19
René Eve COO	Chief Operating Officer	-	2025-08-17

Bioretec Oy Stock BOERSE MUENCHEN

Stocks

0TN

FI4000480454

Medical Equipment, Supplies & Distribution

Valuation: Bioretec Oy

Chart: Bioretec Oy

Latest news : Bioretec Oy

Press Releases: Bioretec Oy

Quotes and Performance

Course Extremes

Managers and Directors: Bioretec Oy

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

Director	Title	Age	Since
Michael Piccirillo BRD	Director/Board Member	67	2017-12-31
Päivi Helena Malinen BRD	Director/Board Member	54	2022-04-12
Kustaa Poutiainen CHM	Chairman	-	2025-03-20

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIORETEC OY	0.00%	-17.43%	-89.33%	-91.85%	32.69M
PENUMBRA, INC.	-0.24%	+0.51%	+38.87%	+4.85%	12.54B
GETINGE AB	0.00%	-0.73%	+16.43%	+16.58%	6.47B
ASAHI INTECC CO., LTD.	+5.03%	-0.56%	+47.84%	+24.50%	5.48B
MINIMED GROUP, INC.	+2.97%	+2.36%	-	-	4.73B
APT MEDICAL INC.	+0.54%	+2.17%	-27.28%	+18.54%	4.32B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+1.50%	-1.03%	-24.75%	-21.63%	3.92B
NOVOCURE LIMITED	+1.87%	+6.52%	+45.88%	-49.96%	2.06B
IMPLANTICA AG	+0.17%	-2.48%	-13.76%	+200.82%	1.72B
NAKANISHI INC.	+4.41%	+4.75%	+61.94%	-1.54%	1.55B
Average	+1.23%	-0.49%	+6.20%	+11.15%	4.75B
Weighted average by Cap.	+1.22%	-0.94%	+21.12%	+14.03%

	2025	2026 *
Net sales	3.8M 4.32M 3.54M 3.25M 6.1M 415M 6.18M 42.05M 16.42M 205M 16.23M 15.88M 707M	5.2M 5.92M 4.84M 4.45M 8.35M 567M 8.46M 57.54M 22.47M 280M 22.2M 21.73M 968M
Net income	-9.6M -10.92M -8.94M -8.21M -15.41M -1.05B -15.61M -106M -41.49M -517M -40.99M -40.11M -1.79B	-7.4M -8.42M -6.89M -6.33M -11.88M -807M -12.04M -81.88M -31.98M -399M -31.6M -30.92M -1.38B
Net Debt	-4.4M -5.01M -4.1M -3.76M -7.06M -480M -7.16M -48.68M -19.01M -237M -18.79M -18.38M -819M	-8.3M -9.44M -7.73M -7.1M -13.32M -905M -13.5M -91.84M -35.87M -447M -35.44M -34.68M -1.55B

1 week	0.02	0.02
1 month	0.02	0.02
3 years	0	0.26